Concomitant |
Multiple Myeloma |
52.3% |
Acute Myeloid Leukaemia |
8.1% |
Non-small Cell Lung Cancer |
7.2% |
Lymphoma Aids Related |
6.1% |
Small Cell Lung Cancer Stage Unspecified |
2.6% |
Glioblastoma |
2.3% |
Lung Neoplasm Malignant |
2.0% |
Myelodysplastic Syndrome |
2.0% |
Renal Cell Carcinoma Stage Unspecified |
2.0% |
Pain |
1.7% |
Pancreatic Carcinoma Metastatic |
1.7% |
Depression |
1.4% |
Drug Use For Unknown Indication |
1.4% |
Macular Oedema |
1.4% |
Pancreatic Carcinoma |
1.4% |
Prophylaxis Against Transplant Rejection |
1.4% |
Anaplastic Large Cell Lymphoma T- And Null-cell Types |
1.2% |
Anaplastic Large-cell Lymphoma, Primary Systemic Type |
1.2% |
Anxiety |
1.2% |
Breast Cancer |
1.2% |
|
White Blood Cell Count Decreased |
12.0% |
Thrombocytopenia |
8.7% |
Vomiting |
8.7% |
Rash |
5.4% |
Syncope |
5.4% |
Transient Ischaemic Attack |
5.4% |
Ventricular Tachycardia |
5.4% |
Angina Unstable |
4.3% |
Metastases To Liver |
4.3% |
Pain |
4.3% |
Pancytopenia |
4.3% |
Pneumonia |
4.3% |
Urinary Retention |
4.3% |
Fatigue |
3.3% |
Multiple Myeloma |
3.3% |
Neuropathy Peripheral |
3.3% |
Perforated Ulcer |
3.3% |
Platelet Count Decreased |
3.3% |
Pleural Effusion |
3.3% |
Pneumaturia |
3.3% |
|